SynthesisThe European journal of health economics : HEPAC : health economics in prevention and care2014

Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison.

Petra Baji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.